Regulations and Standards

What is the current risk of shortages for medicines and medical products due to Brexit? Should there be a no-deal Brexit, then there may be shortages of some medicines and other products due to [...]

The EU Falsified Medicines Directive (2011/62/EU) (FMD) was adopted by the UK in 2011 and will be implemented on 9th February 2019, when the Delegated Regulation on ‘safety features’ will be [...]

The NMC standards for medicines management have been withdrawn from 28th January 2019. This means that these standards will no longer be recognised as the professional guidance for nurses and [...]

What is FMD? First and foremost, the Falsified Medicines Directive is designed to protect patients. The measures this legislation introduces will minimise the risk that counterfeit medicines will [...]

This NICE guideline was published in March 2018 and covers stop smoking interventions and services delivered in primary care and community settings for everyone over the age of 12. It aims to [...]

With the General Data Protection Regulation (GDPR) having come into effect on 25th May 2018, Ashtons, like many other companies, has been ensuring we are fully compliant with all new data [...]

Brain Injury Awareness Week is extremely important in educating people about the dangers of brain injury. The brain is one of the great wonders of the world, controlling everything we do, [...]

This NICE clinical guideline was updated in December 2017 and covers recognising and diagnosing autism spectrum disorder in children and young people from birth up to 19 years. It also covers [...]

The Care Quality Commission has recently published a report on ‘The State of Care in Independent Acute Hospitals’. It is the first inspection of its kind and now gives an in-depth look at the [...]

Falsified medicines include counterfeit and unauthorised medicines and these can pose a health risk for patients. They are often disguised as authentic medicines and may be impossible to detect [...]